Recalls / Class II

Class IID-0395-2026

Product

Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.

Affected lot / code info

Lot 240709, exp 7/31/2026

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm

New Life Pharma LLC

Notification channel

Letter

Type

Voluntary: Firm initiated

Address

265 Livingston St, N/A, Northvale, New Jersey 07647-1901

Distribution

Quantity

45 vials

Distribution pattern

OH

Timeline

Recall initiated

2026-02-26

FDA classified

2026-03-17

Posted by FDA

2026-03-11

Status

Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0395-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.